Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3456

Endovascular Aneurysm Repair Market by Indication [Abdominal Aortic Aneurysm {AAA} and Thoracic Aortic Aneurysm {Ascending Aortic Aneurysm, Descending Aortic Aneurysm, Thoracoabdominal Aortic Aneurysm, and Thoracic Arch Aortic Aneurysm}], Site [Infrarenal and Pararenal {Juxtarenal and Suprarenal}], Anatomy [Traditional, and Complex], and Products [Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Grafts] - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_171879
Pages: 190
May 2017 | 1887 Views
face gplus_n
Author's : Garima Chandra & Divya Srivastava
Tables: 57
Charts: 63
twit_n pr_n

Endovascular Aneurysm Repair Market Overview:

Global Endovascular Aneurysm Repair (Evar) Market was valued at $2,327 million in 2016, and is expected to reach at $3,580 million by 2023, registering a CAGR of 6.2% from 2017 to 2023. Endovascular aneurysm repair (EVAR) is a preferred treatment option for aortic aneurysm given its advantages over open surgery. These advantages include shorter hospital stay, quick recovery time, improved patient outcomes, and no abdominal surgery. Hence, this EVAR procedure is known as standard intervention for abdominal aortic aneurysm (AAA). In this procedure, a stent is placed in an aneurysmal area of the aorta to provide permanent alternative channel for blood flow within the patient’s vasculature, thereby preventing aneurysmal sac from blood flow pressure and rupturing.

The technological advancements in the field of EVAR has led to a shift from open surgery to endovascular repair. Hence, the EVAR technique is becoming a common treatment of choice among patients with aneurysm. As per Clifford Buckley (a surgeon in Central Texas Veterans Healthcare System) in 2013, about 65%-88% of the AAA procedure were performed using EVAR. Most commonly this procedure is witnessed among AAA patients as thoracic aneurysm is rarely found. Hence, abdominal aortic aneurysm has captured major part of the EVAR market.

Although EVAR has significantly reduced the operative risks and recovery time as compared to conventional open surgery, but further improvisations in the EVAR can be easily accomplished. This is because there have been cases of endoleaks post EVAR procedure. However, to meet such challenges, the market players have developed next generation and advanced technologies. For instance, Endologix Inc., recently gained FDA approval for its percutaneous endograft delivery system and possess a game challenging, new generation Nellix technology, a first and only endovascular sealing product useful in mitigation of all types of endoleak.

Different Evar Products Developed By Market Players

ProductIndicationCompany
Aorfix Endovascular Stent GraftAbdominal aortic aneurysm (AAA)Lombard Medical Inc.
AFX Endovascular AAA System.Type III endoleaks, AAAEndologix, Inc.
Endurant II AAA Stent Graft SystemInfrarenal abdominal aortic or aorto-iliac aneurysmsMedtronic plc.
Gore Excluder AAA EndoprosthesisIliac artery aneurysms or aortoiliac aneurysmW. L. Gore & Associates.

Anaconda Stent Graft System

Abdominal Aortic AneurysmTerumo Cardiovascular Systems Corporation


The global endovascular aneurysm repair market is segmented based on indication, products, site, and anatomy. Based on indication, it is classified into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). The thoracic aortic aneurysm is categorized into ascending, descending, thoracoabdominal, and thoracic arch aortic aneurysm. Based on site, it is bifurcated into infrarenal and pararenal. The pararenal market is divided into juxtarenal and suprarenal. In terms of anatomy, it is categorized into traditional and complex. By products, the EVAR market is classified into percutaneous EVAR, fenestrated EVAR, aortic stents & TAA grafts, and others. Among indications, the abdominal aortic aneurysm segment occupied dominant share of 77.9% in 2016, and is expected maintain this trend during the forecast period, owing to high occurrences of abdominal aortic aneurysm disease globally.

Drivers, restraints, and opportunities

The impact of drivers is currently moderate but is expected to increase in future and drive the endovascular aneurysm repair market, owing to high prevalence of abdominal aortic aneurysm disease and growth in geriatric population. The impact of restraints is anticipated to reduce during the forecast period as government is taking robust efforts toward improvement of cost structure of EVAR devices and treatment procedures. Furthermore, government is taking initiatives to increase awareness related to availability of aneurysm treatment procedures and devices.

Global endovascular aneurysm repair (EVAR) market: Key product segment

The abdominal aortic aneurysm accounted for a significant share in the global EVAR market, and this trend is expected to continue during the forecast period.

UK Endovascular Aneurysm Repair (EVAR) Market

Rise in mortality rate due to AAA drives the global EVAR market in UK. For instance, about 19,000 death each year occur in UK, among which half of them is due to AAA. Moreover, UK has adopted screening program of National Health Service (NHS) for early detection of abdominal aneurysm. This has helped in quick diagnosis of the disease, thereby leading to the rise in demand for AAA treatment options, such as EVAR. The market in UK is expected to exhibit the highest CAGR of 5.9% from 2017 to 2023.

The key players in the global endovascular aneurysm repair (EVAR) market include Medtronic plc., Cook Medical Inc., Endologix, Inc., Lombard Medical, Inc., W. L. Gore & Associates, Inc., Cardinal Health Inc., C. R. Bard, Inc., Merck & Co., Inc., Terumo Corporation, and Abbott Laboratories. The other prominent players in the value chain include Volcano Corporation, Spectranetics International BV, AbbVie Inc., Bolton Medical Inc., and Aptus Endosystems Inc.

Key Benefits

  • The study provides an in-depth analysis of the global EVAR market, with current trends and future estimations to elucidate the imminent investment pockets.
  • A quantitative analysis from 2016 to 2023 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Key market players are profiled and their strategies are analyzed thoroughly, which help to understand the competitive outlook of the market.
  • Porter’s Five Forces model is expected to interpret the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players.

Endovascular Aneurysm Repair Market Key Segments:

By Indication

  • Abdominal Aortic Aneurysm (AAA)
  • Thoracic Aortic Aneurysm (TAA)
    • Ascending Aortic Aneurysm
    • Descending Aortic Aneurysm
    • Thoracoabdominal Aortic Aneurysm
    • Thoracic Arch Aortic Aneurysm

By Site

  • Infrarenal
  • Pararenal
    • Juxtarenal
    • Suprarenal

By Anatomy

  • Traditional
  • Complex

By Products

  • Percutaneous EVAR
  • Fenestrated EVAR
  • Aortic Stents & TAA grafts
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Saudi Arabia
    • Republic of South Africa
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY MARKET BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTER’S FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Rising occurrences of aortic aneurysm
3.6.1.2. Growing geriatric population worldwide
3.6.1.3. Technological advancements in EVAR procedures and devices
3.6.1.4. Availability of favorable reimbursement for EVAR procedures and devices

3.6.2. Restraints

3.6.2.1. High cost associated with treatment procedures
3.6.2.2. Lack of awareness in developing region

3.6.3. Opportunities

3.6.3.1. Improvement in EVAR technologies and devices

Chapter: 4 ENDOVASCULAR ANEURYSM REPAIR (EVAR), BY INDICATION

4.1. OVERVIEWGLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET: INDICATION

4.1.1. Market size and forecast

4.2. ABDOMINAL AORTIC ANEURYSM (AAA)

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. THORACIC AORTIC ANEURYSM (TAA)

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Ascending thoracic aortic aneurysm

4.3.4.1. Market size and forecast

4.3.5. Descending thoracic aortic aneurysm

4.3.5.1. Market size and forecast

4.3.6. Thoracic arch aneurysm

4.3.6.1. Market size and forecast

4.3.7. Thoracoabdominal aortic aneurysm (TAAA)

4.3.7.1. Market size and forecast

Chapter: 5 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. INFRARENAL SITE

5.2.1. Market size and forecast

5.3. PARARENAL

5.3.1. Market size and forecast
5.3.2. Juxtarenal

5.3.2.1. Market size and forecast

5.3.3. Suprarenal

5.3.3.1. Market size and forecast

Chapter: 6 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. TRADITIONAL

6.2.1. Market size and forecast

6.3. COMPLEX

6.3.1. Market size and forecast

Chapter: 7 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. PERCUTANEOUS EVAR

7.2.1. Market size and forecast

7.3. FENESTRATED EVAR

7.3.1. Market size and forecast

7.4. AORTIC STENT & TAA GRAFT

7.4.1. Market size and forecast

7.5. OTHERS

7.5.1. Market size and forecast

Chapter: 8 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast

8.2.3.1. U.S. market size and forecast
8.2.3.2. Mexico market size and forecast
8.2.3.3. Canada market size and forecast

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast

8.3.3.1. UK market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. Germany market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast

8.4.3.1. India market size and forecast
8.4.3.2. Japan market size and forecast
8.4.3.3. China market size and forecast
8.4.3.4. Australia market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Thailand market size and forecast
8.4.3.7. Rest of Asia-Pacific market size and forecast

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast

8.5.3.1. Brazil market size and forecast
8.5.3.2. South Africa market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Turkey market size and forecast
8.5.3.5. Rest of LAMEA market size and forecast

Chapter: 9 COMPANY PROFILES

9.1. MEDTRONIC PLC

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments

9.2. COOK MEDICAL INC.

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments

9.3. ENDOLOGIX INC.

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments

9.4. W. L. GORE & ASSOCIATES, INC.

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments

9.5. CARDINAL HEALTH INC.

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments

9.6. C. R. BARD, INC.

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments

9.7. MERCK & CO., INC.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments

9.8. LOMBARD MEDICAL, INC.

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments

9.9. TERUMO CORPORATION

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments

9.10. ABBOTT LABORATORIES

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY INDICATION, 2017-2023 ($MILLION)
TABLE 2. GLOBAL ABDOMINAL AORTIC ANEURYSM (AAA) MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 3. GLOBAL THORACIC AORTIC ANEURYSM (TAA) MARKET, BY TYPE, 2017-2023 ($MILLION)
TABLE 4. GLOBAL ASCENDING AORTIC ANEURYSM MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 5. GLOBAL DESCENDING AORTIC ANEURYSM MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 6. GLOBAL THORACIC ARCH ANEURYSM MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 7. GLOBAL THORACIC ARCH ANEURYSM MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 8. GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 9. GLOBAL EVAR INFRARENAL SITE MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 10. GLOBAL EVAR PARARENAL SITE MARKET, BY TYPE, 2017-2023 ($MILLION)
TABLE 11. GLOBAL EVAR JUXTARENAL SITE MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 12. GLOBAL EVAR SUPRARENAL SITE MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 13. GLOBAL ENDOVADCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 14. GLOBAL EVAR MARKET FOR TRADITIONAL ANATOMY, BY REGION, 2017-2023 ($MILLION)
TABLE 15. GLOBAL EVAR MARKET FOR COMPLEX ANATOMY, BY REGION, 2017-2023 ($MILLION)
TABLE 16. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 17. GLOBAL PERCUTANEOUS EVAR MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 18. GLOBAL FENESTRATED EVAR MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 19. GLOBAL EVAR MARKET FOR AORTIC STENT & TAA GRAFT, BY REGION, 2017-2023 ($MILLION)
TABLE 20. GLOBAL EVAR MARKET FOR OTHER PRODUCTS, BY REGION, 2017-2023 ($MILLION)
TABLE 21. ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 22. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY COUNTRY, 2017-2023 ($MILLION)
TABLE 23. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 24. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 25. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 26. EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY COUNTRY, 2017-2023 ($MILLION)
TABLE 27. EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 28. EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 29. EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY COUNTRY, 2017-2023 ($MILLION)
TABLE 31. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 32. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 33. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 34. LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY COUNTRY, 2017-2023 ($MILLION)
TABLE 35. LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 36. LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 37. LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 38. MEDTRONIC: COMPANY SNAPSHOT
TABLE 39. MEDTRONIC: OPERATING SEGMENTS
TABLE 40. COOK: COMPANY SNAPSHOT
TABLE 41. COOK: OPERATING SEGMENTS
TABLE 42. ENDOLOGIX: COMPANY SNAPSHOT
TABLE 43. ENDOLOGIX: OPERATING SEGMENTS
TABLE 44. GORE : COMPANY SNAPSHOT
TABLE 45. GORE: OPERATING SEGMENTS
TABLE 46. CARDINAL: COMPANY SNAPSHOT
TABLE 47. CARDINAL: OPERATING SEGMENTS
TABLE 48. C. R. BARD: COMPANY SNAPSHOT
TABLE 49. C. R. BARD: OPERATING SEGMENTS
TABLE 50. MERCK: COMPANY SNAPSHOT
TABLE 51. MERCK: OPERATING SEGMENTS
TABLE 52. LOMBARD: COMPANY SNAPSHOT
TABLE 53. LOMBARD: OPERATING SEGMENTS
TABLE 54. TERUMO: COMPANY SNAPSHOT
TABLE 55. TERUMO: OPERATING SEGMENTS
TABLE 56. ABBOTT: COMPANY SNAPSHOT
TABLE 57. ABBOTT: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023
FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2017)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET
FIGURE 13. U.S. ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 14. MEXICO ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 15. U.S. ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 16. UK ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 17. FRANCE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 18. GERMANY ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 19. ITALY ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 20. SPAIN ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 21. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 22. INDIA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 23. JAPAN ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 24. CHINA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 25. AUSTRALIA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 26. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 27. THAILAND ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 28. REST OF ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 29. BRAZIL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 30. REPUBLIC OF SOUTH AFRICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 31. SAUDI ARABIA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 32. TURKEY ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 33. REST OF LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 34. MEDTRONIC: NET SALES, 2014-2017 ($MILLION)
FIGURE 35. MEDTRONIC: REVENUE BY SEGMENT, 2016 (%)
FIGURE 36. MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 37. COOK: NET SALES, 2014-2017 ($MILLION)
FIGURE 38. COOK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 39. COOK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 40. ENDOLOGIX: NET SALES, 2014-2017 ($MILLION)
FIGURE 41. ENDOLOGIX: REVENUE BY SEGMENT, 2016 (%)
FIGURE 42. ENDOLOGIX: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 43. GORE: NET SALES, 2014-2017 ($MILLION)
FIGURE 44. GORE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 45. GORE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 46. CARDINAL: NET SALES, 2014-2017 ($MILLION)
FIGURE 47. CARDINAL: REVENUE BY SEGMENT, 2016 (%)
FIGURE 48. CARDINAL: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 49. C. R. BARD: NET SALES, 2014-2017 ($MILLION)
FIGURE 50. C. R. BARD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 51. C. R. BARD: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 52. MERCK: NET SALES, 2014-2017 ($MILLION)
FIGURE 53. MERCK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 54. MERCK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 55. LOMBARD: NET SALES, 2014-2017 ($MILLION)
FIGURE 56. LOMBARD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 57. LOMBARD: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 58. TERUMO: NET SALES, 2014-2017 ($MILLION)
FIGURE 59. TERUMO: REVENUE BY SEGMENT, 2016 (%)
FIGURE 60. TERUMO: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 61. ABBOTT: NET SALES, 2014-2017 ($MILLION)
FIGURE 62. ABBOTT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 63. ABBOTT: REVENUE BY GEOGRAPHY, 2016 (%)

 

Endovascular aneurysm repair (EVAR) is a minimally invasive alternative to open surgical repair for the treatment of aortic aneurysm. In present scenario, it is a highly-preferred treatment option among aneurysm patients, owing to its several advantages, such as lessened recovery times and enhanced survival rates. Endovascular repair methods intend to reduce the mortality rate in a patient populace that is progressively more older and less fit.

Rise in geriatric population, increase in healthcare expenditure, consistent growth in incidence of AAA screening globally fuel the growth of the EVAR market in the future. Postoperative complexities, such as Endoleaks and stent migration are the challenges confronted by the industry. However, the growth in number of regulations imposed by regulatory authorities, such as FDA confines the market players. A few trends that impact the market includes progressive clinical trials, rise in utilization of percutaneous EVAR, inclinations for different AAA repair strategies, and innovative developments.

The technological advancements in the industry, such as advent of novel stent grafts and sealing systems and catheters have provided the market with accelerated pace and increase the demand for EVAR techniques. Moreover, compatibility of EVAR among patients and several aforementioned benefits have made endovascular aneurysm repair as a standard intervention for abdominal aortic aneurysm treatment.

 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Purchase Full Report of
Endovascular Aneurysm Repair Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts